GMED Globus Medical Inc
Price (delayed)
$72.18
Market cap
$9.93B
P/E Ratio
94.97
Dividend/share
N/A
EPS
$0.76
Enterprise value
$9.68B
Based in Audubon, Pennsylvania, Globus Medical, Inc. was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing
Highlights
Globus Medical's revenue has surged by 61% YoY
The gross profit has grown by 45% YoY and by 3% from the previous quarter
The P/E is 46% more than the 5-year quarterly average of 65.4 but 35% less than the last 4 quarters average of 147.3
GMED's quick ratio is down by 35% year-on-year but it is up by 8% since the previous quarter
GMED's gross margin is down by 10% year-on-year
The debt has increased by 3.2% year-on-year
Key stats
What are the main financial stats of GMED
Market
Valuations
Earnings
Shares outstanding
137.54M
Market cap
$9.93B
Enterprise value
$9.68B
Price to earnings (P/E)
94.97
Price to book (P/B)
2.35
Price to sales (P/S)
3.89
EV/EBIT
77.5
EV/EBITDA
25.55
EV/Sales
3.84
Revenue
$2.52B
Gross profit
$1.48B
Operating income
$165.99M
Net income
$102.98M
EBIT
$124.91M
EBITDA
$378.94M
Free cash flow
$405.21M
Per share
Balance sheet
Liquidity
EPS
$0.76
EPS diluted
$0.75
Free cash flow per share
$2.99
Book value per share
$30.68
Revenue per share
$18.56
TBVPS
$22.28
Total assets
$5.25B
Total liabilities
$1.07B
Debt
$537.19M
Equity
$4.18B
Working capital
$1.32B
Debt to equity
0.13
Current ratio
2.54
Quick ratio
1.69
Net debt/EBITDA
-0.65
Margins
Efficiency
Dividend
EBITDA margin
15%
Gross margin
58.9%
Net margin
4.1%
Operating margin
6.6%
Return on assets
2%
Return on equity
2.6%
Return on invested capital
6.4%
Return on capital employed
2.8%
Return on sales
5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GMED stock price
How has the Globus Medical stock price performed over time
Intraday
-0.85%
1 week
4.02%
1 month
-0.51%
1 year
42.79%
YTD
-12.73%
QTD
-1.39%
Financial performance
How have Globus Medical's revenue and profit performed over time
Revenue
$2.52B
Gross profit
$1.48B
Operating income
$165.99M
Net income
$102.98M
Gross margin
58.9%
Net margin
4.1%
Globus Medical's revenue has surged by 61% YoY
The net margin has declined by 47% year-on-year but it has increased by 11% since the previous quarter
The gross profit has grown by 45% YoY and by 3% from the previous quarter
The operating income has increased by 43% QoQ and by 25% YoY
Growth
What is Globus Medical's growth rate over time
Valuation
What is Globus Medical stock price valuation
P/E
94.97
P/B
2.35
P/S
3.89
EV/EBIT
77.5
EV/EBITDA
25.55
EV/Sales
3.84
The P/E is 46% more than the 5-year quarterly average of 65.4 but 35% less than the last 4 quarters average of 147.3
The EPS has declined by 30% year-on-year but it has grown by 23% since the previous quarter
The stock's P/B is 28% less than its 5-year quarterly average of 3.3 but 3% more than its last 4 quarters average of 2.3
GMED's equity is up by 4.5% year-on-year and by 2.7% since the previous quarter
Globus Medical's revenue has surged by 61% YoY
GMED's P/S is 35% lower than its 5-year quarterly average of 6.0 and 4.4% lower than its last 4 quarters average of 4.1
Efficiency
How efficient is Globus Medical business performance
The return on sales has declined by 46% year-on-year and by 3.8% since the previous quarter
The ROA is down by 39% year-on-year but it is up by 11% since the previous quarter
Globus Medical's return on equity has decreased by 37% YoY but it has increased by 13% QoQ
GMED's ROIC is down by 10% year-on-year but it is up by 3.2% since the previous quarter
Dividends
What is GMED's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GMED.
Financial health
How did Globus Medical financials performed over time
Globus Medical's current ratio has decreased by 48% YoY
GMED's quick ratio is down by 35% year-on-year but it is up by 8% since the previous quarter
The debt is 87% smaller than the equity
GMED's equity is up by 4.5% year-on-year and by 2.7% since the previous quarter
The debt has increased by 3.2% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.